For press inquiries click here to contact us.
Xconomy
Biogen’s Olivier Danos Joins Regenxbio as Chief Scientific Officer
Scrip
NeuroDerm Makes Progress On Simplified Path To Parkinson’s Approval
GenomeWeb
Adaptive Biotechnologies, Amgen to Develop Sequencing-Based ALL Assay
The Huffington Post
An Implant Could Revolutionize The Way We Protect Ourselves From HIV
Ophthalmology Times
Novel ocular hypotensive drug meets endpoints
FierceBiotech
Pfizer wins quick reward from buyout of Anacor with approval of eczema drug expected to be blockbuster
FierceBiotech
Intellia gears up for human testing of CRISPR with new HQ, set to double staffers
The Boston Globe
Intarcia seeks approval of drug-device combo to treat Type 2 diabtes
Fortune
A New Innovation for Type 2 Diabetes
Please see important disclaimers in the Terms section.
